Recombinant Haemophilus somnus Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)

Shipped with Ice Packs
In Stock

Description

Overview and Biochemical Function

Recombinant Haemophilus somnus Succinyl-CoA ligase [ADP-forming] subunit beta (sucC) is a bacterial enzyme critical for energy metabolism. It is a component of succinyl-CoA synthetase (SCS), which catalyzes the reversible conversion of succinyl-CoA to succinate in the tricarboxylic acid (TCA) cycle. This reaction couples the cleavage of the thioester bond in succinyl-CoA with the synthesis of ATP or GTP through substrate-level phosphorylation.

  • Enzyme Commission (EC) Number: 6.2.1.5.

  • Synonyms: SucC, HSM_1432, Succinate--CoA ligase [ADP-forming] subunit beta, SCS-beta.

  • Functional Role:

    • The beta subunit determines nucleotide specificity (ADP vs. GDP) and binds succinate.

    • The alpha subunit binds coenzyme A and phosphate.

Role in Bacterial Metabolism

  • Energy Production: SucC enables ATP generation under anaerobic conditions, which is vital for H. somnus survival in host environments .

  • Virulence Link: Although not explicitly studied for sucC, H. somnus mutants with disrupted TCA cycle components show reduced survival in serum and phagocytes, suggesting metabolic adaptations are critical for virulence .

Industrial and Therapeutic Relevance

  • Enzyme Engineering: Recombinant sucC serves as a tool for studying substrate-level phosphorylation mechanisms and designing inhibitors targeting bacterial energy metabolism.

  • Biochemical Assays: Used to quantify ATP yield in bacterial lysates or reconstituted TCA cycle systems.

Comparative Analysis of Expression Systems

Host SystemAdvantagesLimitations
E. coliHigh yield, cost-effective, rapid growthLimited post-translational modifications
YeastEukaryotic folding, moderate scalabilityLower yield compared to E. coli
BaculovirusComplex protein folding, high purityTime-consuming, expensive

Challenges and Future Directions

  • Functional Studies: Structural characterization (e.g., X-ray crystallography) of H. somnus sucC remains unreported.

  • Pathogenicity Studies: Direct links between sucC activity and H. somnus virulence (e.g., biofilm formation, immune evasion) are underexplored .

  • Therapeutic Potential: Targeting sucC could disrupt bacterial energy homeostasis, but specificity over human SUCLA2/SUCLG2 must be addressed .

Key References

  1. Functional Annotation: UniProt entry B0UUF3 details catalytic residues and domain architecture.

  2. Metabolic Context: H. somnus utilizes TCA cycle adaptations for intracellular survival .

  3. Production Protocols: Commercial vendors (e.g., The BioTek) standardize recombinant sucC production.

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with normal blue ice packs by default. For dry ice shipping, contact us in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
sucC; HSM_1432Succinate--CoA ligase [ADP-forming] subunit beta; EC 6.2.1.5; Succinyl-CoA synthetase subunit beta; SCS-beta
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-389
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Histophilus somni (strain 2336) (Haemophilus somnus)
Target Names
sucC
Target Protein Sequence
MNLHEYQSKK LFADYGLPVT KGYVCENVEQ ALSAIEKLSG SQWIAKCQIH AGGRGKAGGV KVVKSAQEVR SFFTKFLGQR LVTVQTNEQG QPIHQIYLEP CAEIQKELYL SAIIDRSSQR IVFMASSEGG MDIEEVAEKT PHLLHRVTID PLVGAMPYQG RELAFKLGLS GKQIQQFSQI FCQLAKLFVE KDLSLLEINP LVILKNDELF CLDAKVVVDD NALYRHPDLF SMRDLTQEDP REAEAEKWNL NYVALDGNIG CMVNGAGLAM GTMDIIKLHG GRPANFLDVG GGATKERVME AFKIILTDSA VKAVLVNIFG GIVRCDLIAK GIVSAINEIG VSVPVIVRLE GTNADLGREI LAQSNLNLIA VNSLTEAAEQ AVNAAKESE
Uniprot No.

Target Background

Function
Succinyl-CoA synthetase functions in the TCA cycle, coupling succinyl-CoA hydrolysis to ATP or GTP synthesis. This represents the only substrate-level phosphorylation step in the TCA cycle. The beta subunit determines nucleotide specificity and binds succinate. The alpha subunit binds coenzyme A and phosphate.
Database Links

KEGG: hsm:HSM_1432

Protein Families
Succinate/malate CoA ligase beta subunit family

Q&A

What is Haemophilus somnus Succinyl-CoA ligase and its role in bacterial metabolism?

Haemophilus somnus (H. somnus) is a gram-negative coccobacillus that colonizes the mucosal surfaces of cattle but can also cause multisystemic diseases including pneumonia, thrombotic meningoencephalitis, septicemia, abortion, myocarditis, and arthritis . Succinyl-CoA ligase (also called succinate-CoA ligase; SucCD; EC 6.2.1.4 and 6.2.1.5) is a critical enzyme in the citric acid cycle that catalyzes the reversible conversion of succinyl-CoA to succinate with the concomitant formation of a nucleoside triphosphate (NTP) .

The enzyme consists of two different subunits forming a heterodimer or heterotetramer structure. The β subunit (SucC) has a molecular mass of approximately 41-45 kDa and is responsible for binding the NTP, while the α subunit (SucD, 29-34 kDa) binds CoA . This enzyme plays a central role in energy metabolism, connecting the citric acid cycle with substrate-level phosphorylation.

How does the structure of H. somnus SucC differ from other bacterial species?

While the specific structural differences of H. somnus SucC are not extensively documented in the provided search results, comparative structural analysis between SucCD enzymes from different bacterial species suggests conservation of key functional domains. Studies of similar succinyl-CoA synthetases have shown that the binding site for succinate is likely located at the dimer interface .

A detailed structural comparison would require examining:

  • Primary sequence homology with other bacterial SucC proteins

  • Conservation of key catalytic residues

  • Differences in substrate binding regions

  • Unique structural motifs that may influence enzyme activity or stability

This comparative approach allows researchers to identify potential unique characteristics of H. somnus SucC that might be relevant for pathogenicity or metabolism.

What expression systems work best for recombinant H. somnus SucC production?

Escherichia coli remains the most common and effective expression system for bacterial proteins like H. somnus SucC. According to research on recombinant protein production, the accessibility of translation initiation sites is a crucial factor in successful expression . For optimal expression of H. somnus SucC in E. coli, consider the following approach:

  • Vector selection: pET expression systems with T7 promoter offer high-level expression for bacterial proteins.

  • Host strain selection: BL21(DE3) or derivatives are recommended for their reduced protease activity and T7 RNA polymerase expression.

  • Translation optimization: Modifying up to the first nine codons of the mRNA with synonymous substitutions can significantly improve expression success .

  • Fusion tags: Adding solubility-enhancing tags (MBP, SUMO, or TrxA) can improve proper folding and solubility.

The expression conditions should be optimized through systematic testing of induction parameters:

ParameterRange to TestNotes
IPTG concentration0.1-1.0 mMLower concentrations may improve solubility
Induction temperature16-37°CLower temperatures often increase soluble protein yield
Induction time3-24 hoursLonger times at lower temperatures can increase yield
Media compositionLB, TB, M9Rich media (TB) typically produces higher biomass

How can translation initiation sites be optimized for improved expression?

Recent research shows that the accessibility of translation initiation sites is a critical determinant of successful recombinant protein expression . Tools like TIsigner that use simulated annealing to modify codons can significantly improve expression outcomes.

To optimize translation initiation for H. somnus SucC:

  • Analyze the mRNA secondary structure around the start codon using computational tools.

  • Apply synonymous substitutions in the first nine codons to reduce stable secondary structures.

  • Consider the base-unpairing across Boltzmann's ensemble to model accessibility of translation initiation sites .

  • Balance codon optimization with maintaining a reasonable GC content.

This approach can dramatically increase the success rate of expression, as approximately 50% of recombinant proteins fail to be expressed in various host cells .

What purification strategy yields the highest purity and activity of recombinant H. somnus SucC?

A multi-step purification strategy is recommended for obtaining high-purity, active H. somnus SucC:

  • Initial capture: Affinity chromatography using His-tag or other fusion tags (if incorporated).

  • Intermediate purification: Ion exchange chromatography (typically anion exchange at pH 8.0).

  • Polishing step: Size exclusion chromatography to separate native dimers/tetramers from aggregates.

The purification buffer should contain components that maintain enzyme stability:

Buffer ComponentRecommended RangePurpose
HEPES or Tris20-50 mM, pH 7.5-8.0pH stability
NaCl100-300 mMIonic strength
Glycerol5-10%Stability enhancement
DTT or β-ME1-5 mMPreventing oxidation
EDTA0.5-1 mMPreventing metal-catalyzed oxidation

The activity of purified SucC should be verified at each purification step to ensure that functional protein is being retained throughout the process.

What analytical methods are most effective for confirming enzyme activity and substrate specificity?

Multiple complementary approaches should be employed to thoroughly characterize recombinant H. somnus SucC:

  • Spectrophotometric activity assays: Measuring ADP formation through coupled enzyme assays (pyruvate kinase and lactate dehydrogenase) that monitor NADH oxidation at 340 nm.

  • Liquid chromatography/mass spectrometry (LC/MS): This technique provides definitive evidence of CoA-thioester formation with succinate and potential alternative substrates .

  • Kinetic parameters determination: Measure Michaelis-Menten kinetics with varying concentrations of substrates:

ParameterTypical Range for Similar EnzymesMethod
Km for succinate2-5 mMInitial velocity measurements
Km for ATP/ADP0.1-1 mMInitial velocity measurements
Km for CoA0.01-0.1 mMInitial velocity measurements
kcat10-100 s⁻¹Steady-state kinetics
  • Substrate specificity analysis: Based on research with similar enzymes, SucCD enzymes can sometimes form CoA-thioesters with alternative substrates such as malate, adipate, glutarate, and fumarate . Testing these substrates can provide valuable insights into the specificity of H. somnus SucC.

How should experiments be designed to study the effect of different variables on H. somnus SucC activity?

Effective experimental design for studying H. somnus SucC requires a systematic approach as outlined below:

  • Define clear research questions: Formulate specific hypotheses about enzyme function, substrate specificity, or environmental effects.

  • Select appropriate experimental design:

    • For multiple factors: Factorial design to evaluate interaction effects

    • For optimization: Response surface methodology

    • For comparing treatments: Randomized complete block design

  • Control variables rigorously:

    • Temperature (typically 25-37°C)

    • pH (usually 7.0-8.0)

    • Ionic strength

    • Substrate concentrations

    • Enzyme concentration

  • Include proper controls:

    • Positive controls with known activity

    • Negative controls without enzyme

    • Background controls for assay components

  • Replicate experiments adequately:

    • Minimum of three technical replicates

    • At least two independent biological replicates (separate protein preparations)

This systematic approach ensures that the experimental design effectively addresses research questions while controlling for potential confounding factors .

How can mutagenesis studies reveal functional domains in H. somnus SucC?

Site-directed mutagenesis is a powerful approach to probe structure-function relationships in H. somnus SucC:

  • Target selection based on comparative analysis:

    • Conserved residues across bacterial SucC proteins

    • Residues in predicted nucleotide-binding domains

    • Interface residues between α and β subunits

  • Mutation design strategy:

    • Conservative mutations (e.g., Asp to Glu) to probe chemical requirements

    • Non-conservative mutations to dramatically alter properties

    • Alanine-scanning mutagenesis of targeted regions

  • Functional assessment of mutants:

    • Expression level and solubility evaluation

    • Enzyme activity measurements

    • Binding affinity for substrates (ITC or fluorescence methods)

    • Structural integrity (circular dichroism or thermal shift assays)

  • Data analysis framework:

    • Compare kinetic parameters of mutants to wild-type enzyme

    • Correlate activity changes with structural predictions

    • Map critical residues onto homology models

This structured approach helps identify critical functional domains and residues essential for catalysis, substrate binding, or structural integrity.

What strategies can resolve poor expression yields of recombinant H. somnus SucC?

When facing poor expression yields, a systematic troubleshooting approach is essential:

  • Optimize translation initiation:

    • Analyze mRNA secondary structure around the start codon

    • Modify the first 9 codons to enhance translation initiation

    • Consider using translation enhancing elements (e.g., SUMO tag)

  • Adjust expression conditions:

    • Reduce induction temperature (16-20°C)

    • Decrease inducer concentration

    • Extend expression time at lower temperatures

    • Test different growth media formulations

  • Address potential toxicity issues:

    • Use tightly controlled inducible promoters

    • Try expression in specialized host strains (C41/C43)

    • Consider co-expression with molecular chaperones (GroEL/ES, DnaK)

  • Evaluate co-expression with partner subunit:

    • Since SucC functions with SucD, co-expression may improve stability and solubility

    • Design bicistronic or dual plasmid expression systems

Studies have shown that addressing translation initiation site accessibility can dramatically improve success rates for recombinant protein expression, as this is a key factor in expression failure .

How can protein aggregation or insolubility issues be addressed?

Protein aggregation and insolubility are common challenges when expressing recombinant proteins:

  • Fusion with solubility-enhancing tags:

    • MBP (maltose-binding protein)

    • SUMO (small ubiquitin-like modifier)

    • Thioredoxin

    • GST (glutathione S-transferase)

  • Buffer optimization during lysis and purification:

AdditiveConcentration RangeMechanism
Arginine50-500 mMSuppresses aggregation
Glycerol5-20%Stabilizes hydrophobic regions
Non-ionic detergents0.01-0.1%Shields hydrophobic patches
Increased salt300-500 mM NaClShields charge interactions
  • Expression condition modifications:

    • Reduce expression rate through lower temperature (16-20°C)

    • Use minimal concentrations of inducer

    • Try auto-induction media for gradual protein production

  • Co-expression strategies:

    • Molecular chaperones (GroEL/ES, DnaK/DnaJ)

    • Partner protein (SucD) for stabilization

These approaches can significantly improve the solubility and stability of recombinant H. somnus SucC during expression and purification.

How should researchers approach contradictory kinetic data for H. somnus SucC?

When facing contradictory kinetic data, a systematic approach to analysis and troubleshooting is essential:

  • Thoroughly examine the data to identify discrepancies:

    • Compare with existing literature

    • Pay attention to outliers that may have influenced results

    • Conduct a comprehensive analysis to gain insights into contradictory data

  • Evaluate initial assumptions and research design:

    • Review assay conditions and methodology

    • Assess enzyme quality and stability during measurements

    • Consider whether experimental conditions accurately reflect the physiological environment

  • Consider alternative explanations:

    • Allosteric regulation mechanisms

    • Substrate inhibition at high concentrations

    • Multiple conformational states with different activities

    • Presence of inhibitors or activators in the preparation

  • Refine the variables and implement additional controls:

    • Implement careful controls for enzyme quality and stability

    • Test for time-dependent changes in activity

    • Evaluate buffer components for potential inhibitory effects

For substrate specificity studies, where contradictions might arise, confirming the formation of CoA-thioesters using methods such as liquid chromatography/electrospray ionization-mass spectrometry is crucial, as demonstrated in studies of similar enzymes .

What statistical approaches are appropriate for analyzing enzymatic activity data?

  • Preliminary data assessment:

    • Test for normality (Shapiro-Wilk or Kolmogorov-Smirnov tests)

    • Assess homogeneity of variance (Levene's test)

    • Identify and address outliers (Grubbs' test)

  • Statistical tests for comparing conditions:

    • Paired t-test for before/after comparisons

    • ANOVA for multiple conditions, followed by post-hoc tests (Tukey's HSD)

    • Non-parametric alternatives (Mann-Whitney U or Kruskal-Wallis) if normality assumptions are violated

  • Regression analysis for kinetic parameters:

    • Non-linear regression for direct fitting to Michaelis-Menten equation

    • Linear transformations (Lineweaver-Burk, Eadie-Hofstee) for visual inspection

    • Global fitting approaches for complex kinetic models

  • Reporting standards:

    • Always include measures of variability (standard deviation or standard error)

    • Report sample sizes and p-values

    • Include confidence intervals for kinetic parameters

ParameterRecommended AnalysisReporting Format
KmNon-linear regressionValue ± SE with 95% CI
VmaxNon-linear regressionValue ± SE with 95% CI
Substrate specificityANOVA with post-hoc testsp-values and effect sizes
Inhibition studiesIC50 by non-linear regressionValue ± SE with 95% CI

These statistical approaches ensure robust analysis of enzymatic data while avoiding common pitfalls in data interpretation.

How can structural studies of H. somnus SucC contribute to understanding its function?

Structural studies provide crucial insights into enzyme mechanism and substrate specificity:

  • X-ray crystallography approach:

    • Purify to >95% homogeneity with size-exclusion chromatography

    • Screen crystallization conditions systematically

    • Co-crystallize with substrates, products, or analogs

    • Analyze active site architecture and binding interactions

  • Cryo-electron microscopy alternatives:

    • Particularly valuable for studying the complete SucCD complex

    • Can reveal conformational changes during catalysis

    • May capture different functional states

  • Computational structure prediction and analysis:

    • Homology modeling based on related bacterial SucC structures

    • Molecular dynamics simulations to study conformational flexibility

    • Docking studies to investigate substrate binding modes

  • Structure-guided investigations:

    • Design mutations based on structural insights

    • Engineer substrate specificity based on binding pocket architecture

    • Understand species-specific differences in enzyme properties

Studies of related enzymes have shown that the binding site for the substrate (succinate) is likely located at the dimer interface , highlighting the importance of studying the complete complex rather than isolated subunits.

How might H. somnus SucC be leveraged for comparative studies with other bacterial species?

Comparative studies between H. somnus SucC and orthologs from other bacteria can provide valuable insights:

  • Evolutionary relationship analysis:

    • Phylogenetic analysis of SucC sequences across bacterial species

    • Identification of conserved and variable regions

    • Correlation of sequence differences with ecological niches or pathogenicity

  • Functional comparison approaches:

    • Parallel expression and characterization of SucC from multiple species

    • Comparison of kinetic parameters and substrate preferences

    • Investigation of species-specific regulatory mechanisms

  • Chimeric enzyme construction:

    • Domain swapping between H. somnus and other bacterial SucC proteins

    • Identification of regions responsible for specific functional properties

    • Engineering of enzymes with novel properties

  • Host specificity studies:

    • Compare SucC from pathogens of different host organisms

    • Investigate potential adaptations to host environments

    • Identify features unique to pathogens versus non-pathogens

Research has shown that SucCD enzymes from different bacterial species can exhibit varied substrate specificities, including the ability to form CoA-thioesters with malate, adipate, glutarate, and fumarate . These variations may reflect ecological adaptations and could provide insights into H. somnus pathogenicity.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.